Revvity, Inc. (RVTY) reported first-quarter 2025 financial results with adjusted earnings per share (EPS) of $1.01, surpassing the consensus estimate of $0.95. The company posted revenue of $664.76 million, slightly above the expected $661.18 million, reflecting 2% reported growth and 4% organic growth. Revvity reaffirmed its full-year 2025 guidance for organic growth and adjusted EPS. The strong quarterly performance was driven by steady demand for medical equipment, with revenue, earnings, and cash flow all exceeding forecasts. Additionally, several financial institutions reported their first-quarter 2025 results, including BankUnited, Inc. (BKU), Sierra Bancorp (BSRR), FirstSun Capital Bancorp (FSUN), Enterprise Financial Services Corp (EFSC), Ameris Bancorp (ABCB), Chain Bridge Bancorp, Inc. (CBNA), Tenet Healthcare Corporation (THC), Zebra Technologies Corporation (ZBRA), Xylem Inc (XYL), and Shift4 Payments, Inc. (FOUR). These reports collectively contribute to the broader financial sector's first-quarter earnings season.